Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of radiation therapy oncology group 93-05 protocol: In regard to Souhami et al. [5] (multiple letters)

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 1, 2005, Pages 296-297

  Vordermark, Dirk ^a   Kölbl, Oliver ^a   Souhami, Luis ^b   Podgorsak, Ervin B ^b   Mehta, Minesh P ^c   Brachman, David ^d   Werner Wasik, Maria ^e   Curran Jr , Walter J ^e   Lustig, Robert ^f   Schultz, Christopher J ^g   Sause, William ^h   Okunieff, Paul ⁱ   Buckner, Jan ^j   Zamorano, Lucia ^k  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d Oncology Services   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h LDS HOSPITAL   (United States)

ⁱ UNIVERSITY OF ROCHESTER   (United States)

^j MAYO CLINIC   (United States)

^k WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; LOMUSTINE; TEMOZOLOMIDE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; GLIOBLASTOMA; HUMAN; LETTER; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIOSURGERY; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE; TUMOR RECURRENCE;

EID: 20944436687     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.01.046     Document Type: Letter

References (9)

1. L. Souhami W. Seiferheld D. Brachman Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme Report of Radiation Therapy Oncology Group 93-05 protocol Int J Radiat Oncol Biol Phys 60 2004 853 860
2. M.M. Fitzek A.F. Thornton J.D. Rabinov Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme Results of a phase II prospective trial J Neurosurg 1999 251 260
3. D.C. Shrieve A. Eben P.M. Black Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost Prognostic factors and long-term outcome J Neurosurg 90 1999 72 77
4. B.G. Baumert J. Lutterbach R. Bernays Fractionated stereotactic radiotherapy after post-operative radiotherapy in patients with high-grade gliomas Radiother Oncol 67 2003 183 190
5. J.L. Chan S.W. Lee B.A. Fraass Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy J Clin Oncol 20 2002 1635 1642
6. U. Oppitz D. Maessen H. Zunterer 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation Radiother Oncol 53 1999 53 57
7. R. Miraminoff W. Mason R. Kortmann Radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus radiotherapy alone for newly diagnosed glioblastoma (GBM): Overall results and recursive partitioning analysis (RPA) of a phase III randomized trial of the EORTC Brain Tumor and Radiotherapy Groups and the NCIC Clinical Trial Group [abstract] Int J Radiat Oncol Biol Phys 60 Suppl. 1 2004 S162
8. C. Wild-Bode M. Weller A. Rimmer Sublethal irradiation promotes migration and invasiveness of glioma cells Implications for radiotherapy of human glioblastoma Cancer Res 61 2001 2744 2750
9. W. Wick A. Wick J.B. Schulz Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase Cancer Res 62 2002 1915 1919